Dipyridamole

Country of origin: Croatia, Vector Russia, New Farm/Vector Canada

Pharm-Group: Antiplatelet agents

Manufacturers: Belupo Ltd (Croatia), Vector (Russia), New Farm/Vector (Canada)

International name: Dipyridamole

Synonyms: Apo-Dipyridamole, Dipyridamole-Ferein, Curantyl, Curantyl N25, Curantyl N25 (Dipyridamole), Curantyl N75, Curantyl N75 (Dipyridamole), Parsedyl, Penseline, Persantine, Trombonil

Dosage forms: film-coated tablets 75 mg, film-coated tablets 25 mg, film-coated tablets 25 mg

Composition: Active ingredient - dipyridamole.

Indications for use: Prevention of thromboembolic syndrome after heart valve replacement surgery, prevention of occlusion of stents and coronary artery bypass grafts (in combination with aspirin), peripheral vascular lesions, prevention of placental insufficiency during complicated pregnancy, treatment and prevention of disseminated intravascular coagulation syndrome in children with infectious toxicoses and septicemia, three-component treatment of glomerulonephritis, platelet suppression syndrome in children, dipyridamole-thallium-201 perfusion scintigraphy with exercise, dipyridamole stress echocardiography.

Contraindications: Hypersensitivity, acute myocardial infarction, severe atherosclerotic lesions of the coronary vessels with a developed collateral system, predisposition to hypotension, severe intraventricular conduction disturbances, severe arterial hypertension, severe liver dysfunction, hemorrhagic diathesis, obstructive pulmonary diseases, II and III trimesters of pregnancy, childhood and adolescence (up to 12 years).

Side effects: Nausea, abdominal discomfort, facial flushing, coronary steal syndrome (exacerbation of coronary heart disease), headaches, dizziness, bleeding, hypotension, thrombocytopenia, changes in the functional properties of platelets, tachycardia